Patient Guide: Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 273 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05409066
Status: ACTIVE_NOT_RECRUITING
Condition: Follicular Lymphoma (FL)
Phase: PHASE3

Find a Study Location Near You

This study is available at 273 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Little Rock, Arkansas
  • Berkeley, California
  • • And 270 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily